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Purpose/Objective: To evaluate the correlation between the 
reference DWH of bladder wall (DWH) outlined by using MRI images 
and DVH of bladder including filling, dose surface (DSH) and DVH of 
artificial bladder wall in prostate cancer patients planned both with 
3D-conformal and IMRT techniques. 
Materials and Methods: 27 prostate cancer patients were submitted 
to CT and MRI scans that were used to draw bladder walls. External 
bladder surfaces were then used to create artificial bladder walls 
applying automatic contractions of 5 (DVH5), 7 (DVH7) and 10 mm 
(DVH10). For each patient a 3DCRT (box technique) and an IMRT (5 
fields) treatment plan was generated prescribing at ICRU reference 
point 77.4 Gy (1.8 Gy/fr) to PTVprostate and 61.2 Gy (1.8 Gy/fr) to 
PTVprostate+seminal vesicle Gy(1.8Gy/fr). For all the patients the 
mean difference and standard deviation between the DWH and the 
other surrogates, both in percentage (%) and absolute volume(cm3), 
was calculated and considered for the analysis. Correlation was 
quantified for selected dose-volume/surface parameters by R 
Spearman correlation coefficient. 
Results: %DWH was found to be correlated to DVH5, DVH7 and DVH10 
(maximum average deviations below 2%, SD<5%) with DVH5 that 
showed the best agreement. Slightly better correlation was found for 
absolute (R=0.80-0.94) compared to relative (R = 0.66-0.92) 
histograms. DSH was also foundto be highly correlated to DWH 
(maximum difference<2% and 9% for 3DCRT andIMRT, respectively, 
and R>0.64), although slightly higher deviations were generally found. 
DVH was not a good surrogate of DWH (R<0.7 for most ofparameters). 
When comparing the two treatment techniques, Spearman’s 
correlation coefficients were significantly lower for IMRT compared to 
3DCRT both in relative (p=0.002) and absolute (p=0.0007) values. 
Conclusions: DVH of the bladder including filling wasn’t a good 
surrogate of DWH. DSH resulted to be correlated to DWH as well as 
DVH5,7,10 with slightly better results for absolute compared to 
relative histograms. As far as treatment planning techniques, 
Spearman’s correlation coefficients for IMRT planning resulted 
significantly lower compared to 3DCRT.  
These results suggest to use DVH of the bladder wall obtained by 
performing automatic 3D contractions of external surface of the 
bladder inclinical practice.  
The study is supported by a grant from Associazione Italiana Ricerca 
sul Cancro (AIRC-IG13090) 
   
PD-0583   
Parotid density and volume variation in IMRT for head-neck cancer: 
predicting final changes from early variations 
M.L. Belli1, E. Scalco2, C. Fiorino1, S. Broggi1, N. Dinapoli3, F. 
Ricchetti4, G. Sanguineti4, V. Valentini3, G. Rizzo2, G.M. Cattaneo1 
1Fondazione Centro San Raffaele, Medical Physics, Milano, Italy  
2CNR, Istituto di Bioimmagini e Fisiologia Molecolare, Milano, Italy  
3Università Cattolica del Sacro Cuore, Radiotherapy, Roma, Italy  
4The Johns Hopkins University, Radiotherapy, Baltimore MD, USA  
 
Purpose/Objective: The large amount of images taken during image 
guided/adaptive treatments, increases the possibility to assess the 
early response of tissues to the treatment. The possibility of early 
(i.e. during the first weeks of treatment) measuring image-based 
parameters that may potentially predict the outcome of the 
treatment in terms of both tumour response and toxicity is of 
particular interest. 
Regarding head-and-neck cancer (HNC), parotid glands (PGs) are 
known to experience large deformation and this may be related to 
acute toxicity (i.e. xerostomia). The aim of this study is to found 
image based score parameters that could be useful to early predict 
final PG variations. 
Materials and Methods: 92 PGs (46 patients) from two Institutions 
(group A and B) were analyzed based on CT images acquired during 
IMRT treatment. Patients were treated with radiotherapy (+ 
concomitant chemotherapy) to 58.1/70 Gy in 35 fractions (median 
values, dose of tumor and nodes PTVs), 29 with SIB approach. For all 
patients, diagnostic kVCT images were acquired at the begin of the 
treatment and at the end and additional kVCTs were acquired during 
the treatment, weekly in group A, one at mid-treatment in group B. 
Image registration was performed between initial CT and the others, 
using an in home developed non-rigid approach based on free-form 
deformation (FFD) and B-splines. PG contours, drawn by experts on 
the initial CT, were automatically propagated to the other images 
using a previously validated algorithm. 
PG deformations were described by the rates of density variation (rΔρ 
[HU/day]), volume variation (rΔvol [mm3/day]) in different parts of 
treatment. Student t-test, multi-variate logistic (MVA) including ROC 
curve analysis and assessment of predictive value of the models based 
on area under the curve (AUC) evaluations were performed. 
Results: As shown in Figure 1, PG density and volume rates are larger 
during the first weeks of treatment, especially for density rate 
variation r?ρ where it results to be highly significant (group A: -0.495 
vs -0.046, p-value=0.0001). When considering the risk of experiencing 
a large density or volume change at the end of therapy (defined as a 
value larger of the quartile of the population), logistic regression 
indicates that they can be predicted by the changes in the first two 
weeks with a moderately high predictive value (AUC > 80%). Similar 
results with a lower predictive value (AUC around 70%) were found 
when looking to the mid-term changes of A+B groups. 
 
  
Conclusions: The rate of PG volume and density variations is larger at 
the begin of the treatment; this effect is more pronounced for density 
changes. Based on the early variations, it is possible to predict with a 
good approximation the final PG changes. This result may be used to 
early identify patients which may be subject to larger variations and 
then possibly selected for adaptive re-planning. 
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Purpose/Objective: The development of the Utrecht design, hybrid 
1.5T MRI linear accelerator offers the ability to perform online MRI-
guided adaptive radiotherapy (ART). This MRI guided ART allows for 
the creation of an optimal treatment plan on the actual anatomy for 
every single treatment fraction. Hereby margins can be reduced due 
to the absence of inter fraction motion and set-up errors. 
Additionally, MRI's superior soft-tissue contrast allows direct tumor 
visualization instead of indirect features used on a CT. These features 
open the possibility for dose escalation. Yet this daily optimization 
requires a fast automated contour propagation and treatment 
planning to be feasible in clinical practice. We propose and evaluate 
an automated workflow for online MRI guided ART for rectal cancer 
boost therapy. 
Materials and Methods: Until now, 10 rectal cancer patients (T2-3 N0-
1 M0-1) underwent pre-treatment and 3-4 consecutive daily fraction 
T2 MR scans. Pre-treatment target volumes and OAR were delineated 
by an experienced radiation oncologist. These contours were then 
propagated to the 3 or 4 consecutive daily fraction MRI's by 
deformable image registration (DIR) of the pre-treatment MRI to the 
fraction MRI. This automated propagation was performed via a multi 
step approach (consecutive Euler, affine and B-spline transforms) 
using the Elastix toolkit (Klein 2010). PTV margins between 1 - 8 mm 
in plane and 4 - 8 mm out of imaging plane, were then applied to the 
transformed CTV and GTV. For each margin, a 7 beam IMRT boost 
treatment plans was made. A dose of 50 Gy was prescribed to the 
PTVCTV and a total dose of 60 Gy was prescribed to the PTVGTV. For 
planning, a fast Monte Carlo based IMRT planning system was used 
(Bol 2012). The dosimetric evaluation of the treatment plans was done 
on golden standard contours. These are obtained by manual correction 
and approval by radiation oncologist of the propagated contours. D99% 
of the gold standard CTV and GTV were evaluated. When a D99% 
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coverage of at least 95% of the prescribed dose was achieved, the 
treatment plan would be considered as clinical acceptable.  
Results: D99% coverage for the gold standard CTV was achieved in for 
69% of the patients using a margin of 1/4 mm in/out of plane, for the 
propagated CTV, which is about the voxel size of the MRI. D99% 
coverage for the gold standard GTV of was achieved for 89% of the 
patients using a margin of 8/8 mm in/out of plane for the propagated 
GTV. OAR doses remained far less then clinical criteria in all 
treatment plans. All treatment plans were made using a class solution 
objectives set. 
 
 
Conclusions: Online MRI-guided ART seems feasible using only a small 
margin added to the automatically generated contours. Failures were 
seen only in patients with large daily variations in rectum filling. 
Currently, the used DIR method cannot account for these large 
deformations. Further improvements on the DIR have to be made to 
make feasible treatment plans for these patients in an automated 
workflow. For delivering the GTV boost, a somewhat larger margin 
was needed and needs to be further optimized.  
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Purpose/Objective: Hyperthermia is a clinical application of heat in 
which tumour temperatures are raised to 40-45°C. Hyperthermia is a 
proven radiosensitizer, which significantly improves clinical outcome 
for several tumour sites. Contrary to most anti-cancer treatments 
hyperthermia has no serious side effects when administered properly. 
Therefore, hyperthermia might be a good alternative for dose 
escalation, for instance for treatment of prostate tumours. This is 
expected to improve tumour control, while avoiding an increase in 
dose to organs at risk; e.g. the rectum. 
Purpose: of this study was to develop a method to quantify the 
therapeutic effect of radiosensitization by hyperthermia. To this end, 
a numerical method was proposed to convert radiotherapy dose 
distributions with hyperthermia to equivalent dose distributions 
without hyperthermia. 
Materials and Methods: For 15 prostate cancer patients clinical IMRT 
plans were created. Patients received a total dose of 70 Gy on the 
PTV, delivered in 35 fractions of 2 Gy, with an integrated boost 
delivering 77 Gy to the prostate. To simulate a clinically relevant 
heterogeneous temperature distribution, hyperthermia treatment 
planning was performed for heating with the 70 MHz AMC-8 system 
using our in-house developed treatment planning system. The 
temperature dependent parameters α (Gy-1) and β (Gy-2) of the linear-
quadratic model (LQ-model) for prostate cancer were estimated from 
literature. In line with clinical observations, no thermal effect was 
assumed for normal tissue. The IMRT plans and temperature 
distributions were exported to our in-house developed research 
radiotherapy treatment planning system and equivalent dose 
distributions without hyperthermia were calculated using the LQ-
model. 
Results: The average tumour temperatures T90, T50 and T10 in the 
PTV were 40.5°C, 41.6°C and 42.4°C, respectively. The minimum, 
maximum and average radiotherapy doses were 62.9 Gy, 81.0 Gy and 
76.0 Gy, respectively. The equivalent minimum, maximum and 
average dose reflecting the radiosensitization by hyperthermia were 
70.3 Gy, 93.6 Gy and 86.3 Gy, respectively, for a linear increase of α 
with temperature. This can be considered similar to a dose escalation. 
Furthermore, the PTV coverage by the 95% isodose level improved by 
adding hyperthermia (Fig. 1). In IMRT dose optimization the dose to 
organs at risk (e.g. the rectum) can be a limiting factor, yielding 
under-dosage in a part of the PTV. Hyperthermia reduces the impact 
of these limitations. 
 
 
Conclusions: A model to quantify the effect of combined 
hyperthermia and radiotherapy in terms of equivalent dose 
distributions was presented. Adding hyperthermia can be considered 
similar to a dose escalation. This model is useful to predict interaction 
of different cancer treatments and may be very helpful in discussions 
on dose escalation.  
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Purpose/Objective: Historically a number of techniques have been 
described that use combined photon and electron fields to conform 
the dose with depth. In recent years however this sort of treatment 
has largely been replaced with photon IMRT. It is proposed that to 
further improve dose distributions electron fields could be re-
introduced to IMRT. The electron beam limited range and large 
penumbra could be balanced by modulating with photon MLC and 
combining with existing photon IMRT techniques. By finding the 
optimum mix of electron energies and photons it may be possible to 
reduce exposure to critical organs and reduce integral doses. The 
perceived disadvantages of high surface dose characterising electron 
beams becomes an advantage for cases where the CTV extends to the 
surface. 
The purpose of this study is to develop a novel optimisation algorithm 
for combined electron and photon IMRT that allows spatial and energy 
modulation with standard unmodified linacs. 
Materials and Methods: Isocentric electron beamlets delivered 
through the photon MLC of an Elekta linac were calculated using 
BEAMnrc Monte Carlo dose simulations. The CERR environment (A 
Computational Environment for Radiotherapy Research, Washington 
University Medical Centre) was used to manipulate the electron 
beamlets and to calculate photon beamlets using the quadrant infinite 
beam (QIB) dose calculation engine within CERR. An algorithm was 
then developed to optimise the combined electron and photon dose 
distribution. Beams are manually positioned to cover the target, with 
a single electron field positioned as a boost over the superficial 
section of tumour. The optimisation is then split into three stages. (1) 
